These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23279742)

  • 1. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
    Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
    Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
    Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
    Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
    Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis.
    Xue X; Li Y; Zhang S; Yao Y; Peng C; Li Y
    Phytomedicine; 2024 Sep; 132():155830. PubMed ID: 38959553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl
    Wang R; Zhang D; Tang D; Sun K; Peng J; Zhu W; Yin S; Wu Y
    Int Immunopharmacol; 2021 Jan; 90():107151. PubMed ID: 33296784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation.
    Wang YG; Xu L; Wang T; Wei J; Meng WY; Wang N; Shi M
    World J Gastroenterol; 2015 Jul; 21(27):8326-39. PubMed ID: 26217084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticolon cancer activity of largazole, a marine-derived tunable histone deacetylase inhibitor.
    Liu Y; Salvador LA; Byeon S; Ying Y; Kwan JC; Law BK; Hong J; Luesch H
    J Pharmacol Exp Ther; 2010 Nov; 335(2):351-61. PubMed ID: 20739454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Largazole, an inhibitor of class I histone deacetylases, attenuates inflammatory corneal neovascularization.
    Zhou H; Jiang S; Chen J; Ren X; Jin J; Su SB
    Eur J Pharmacol; 2014 Oct; 740():619-26. PubMed ID: 24973692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Therapeutic Mechanisms of Propolis Against CCl
    Badr G; Sayed EA; Waly H; Hassan KA; Mahmoud MH; Selamoglu Z
    Cell Physiol Biochem; 2019; 53(2):301-322. PubMed ID: 31343125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway.
    Cai S; Wu L; Yuan S; Liu G; Wang Y; Fang L; Xu D
    Eur J Pharmacol; 2021 May; 898():173982. PubMed ID: 33647257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoid-rich Scabiosa comosa inflorescence extract attenuates CCl
    Ma Y; Yuan H; Jin R; Bao X; Wang H; Su X; Mu MGSL; Liang J; Zhang J; Wu X
    Biomed Pharmacother; 2018 Oct; 106():426-433. PubMed ID: 29990830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New role and molecular mechanism of Gadd45a in hepatic fibrosis.
    Hong L; Sun QF; Xu TY; Wu YH; Zhang H; Fu RQ; Cai FJ; Zhou QQ; Zhou K; Du QW; Zhang D; Xu S; Ding JG
    World J Gastroenterol; 2016 Mar; 22(9):2779-88. PubMed ID: 26973416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.
    Liu Y; Wang Z; Kwong SQ; Lui ELH; Friedman SL; Li FR; Lam RWC; Zhang GC; Zhang H; Ye T
    J Hepatol; 2011 Sep; 55(3):612-625. PubMed ID: 21251937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway.
    Ding Q; Li Z; Liu B; Ling L; Tian X; Zhang C
    Hum Pathol; 2018 Jun; 76():37-46. PubMed ID: 29514109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway.
    Wang Y; Zhao L; Jiao FZ; Zhang WB; Chen Q; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):423-429. PubMed ID: 30249543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats.
    Lin N; Chen S; Pan W; Xu L; Hu K; Xu R
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C469-77. PubMed ID: 21543745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.
    Du G; Wang J; Zhang T; Ding Q; Jia X; Zhao X; Dong J; Yang X; Lu S; Zhang C; Liu Z; Zeng Z; Safadi R; Qi R; Zhao X; Hong Z; Lu Y
    Cell Death Dis; 2020 Feb; 11(2):118. PubMed ID: 32051399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling.
    Liu Y; Lui EL; Friedman SL; Li L; Ye T; Chen Y; Poon RT; Wo J; Kok TW; Fan ST
    Lab Invest; 2009 Feb; 89(2):209-21. PubMed ID: 19114984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.